The quantitative analysis of CCR2 protein levels across tumor types showed a wide range of scores with consistently higher expression in NSCLC samples, followed by PDAC samples, and lower levels in CRC samples (Fig. 6B). Here, CCR2 is linked to colorectal carcinoma.